本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ProKidney Corp.

2.24
+0.01000.45%
盤後2.240.0015+0.07%18:59 EST
成交量:39.58萬
成交額:88.32萬
市值:6.74億
市盈率:-4.12
高:2.28
開:2.22
低:2.18
收:2.23
52周最高:7.13
52周最低:0.4603
股本:3.01億
流通股本:2.74億
量比:0.69
換手率:0.14%
股息:- -
股息率:- -
每股收益(TTM):-0.5433
每股收益(LYR):-0.6249
淨資產收益率:-41.81%
總資產收益率:-25.85%
市淨率:-0.67
市盈率(LYR):-3.58

資料載入中...

2026/02/03

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2025/11/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/10

重要事件披露

Form 8-K - Current report
2025/11/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/17

重要事件披露

Form 8-K - Current report
2025/08/13

重要事件披露

Form 8-K - Current report
2025/08/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/15

重要事件披露

Form 8-K - Current report
2025/07/14

重要事件披露

Form 8-K - Current report
2025/07/08

關聯方擬減持公告

Form 144 | PROKIDNEY高管 Darin J Weber 擬減持103480股,總價約62760.62美元
2025/07/08

重要事件披露

Form 8-K - Current report
2025/07/03

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/03

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/03

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/03

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/01

重要事件披露

Form 8-K - Current report
2025/05/30

重要事件披露

Form 8-K - Current report
2025/05/12

重要事件披露

Form 8-K - Current report